Autres langues HLB bioStep Co.,Ltd.

Actions

A278650

KR7278650007

Cours en clôture Korea S.E. Autres places de cotation 00:00:00 14/05/2024			Varia. 5j.	Varia. 1 janv.
3 295 ^KRW	+0,15%		-7,18%	+6,63%

08/02	HLB bioStep Co.,Ltd. (KOSDAQ:A278650) annonce un rachat d'actions pour une valeur de 2 000 millions KRW.	CI
08/02	HLB bioStep Co. autorise un plan de rachat.	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

HLB bioStep Co.,Ltd. announced that it expects to receive KRW 1.438165744 billion in funding from Kangstem Biotech Co., Ltd.	25/04
Tranche Update on HLB bioStep Co.,Ltd.'s Equity Buyback Plan announced on December 4, 2023.	08/03
HLB bioStep Co.,Ltd. announces an Equity Buyback for KRW 2,000 million worth of its shares.	08/02
HLB bioStep Co.,Ltd. authorizes a Buyback Plan.	08/02
HLB bioStep Co.,Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.	04/12
HLB bioStep Co.,Ltd. authorizes a Buyback Plan.	04/12
Panagene Inc. announced that it expects to receive KRW 56.599994061 billion in funding from a group of investors	21/06/23
Panagene Inc. announced that it expects to receive KRW 46.068324061 billion in funding from HLB Co., Ltd., HLB Investment Co., Ltd., HLB bioStep Co.,Ltd., HLB innoVation Co.,Ltd., HLB Therapeutics Co.,Ltd.	21/06/23
HLB innoVation Co.,Ltd. announced that it has received KRW 55.99999522 billion in funding from a group of investors	13/03/23
HLB SCIENCE Inc. announced that it has received KRW 5.0000004 billion in funding from HLB bioStep Co.,Ltd.	09/02/23
HLB SCIENCE Inc. announced that it expects to receive KRW 5.0000004 billion in funding from HLB bioStep Co.,Ltd.	01/02/23
HLB innoVation Co.,Ltd. announced that it expects to receive KRW 55.99999522 billion in funding from a group of investors	01/02/23
KNOTUS Co.,Ltd's Equity Buyback announced on March 13, 2020 has expired with 71,714 shares, representing 0.98% for KRW 960.15 million.	12/03/22
KNOTUS Co.,Ltd announced that it has received KRW 81.1 billion in funding	13/01/22
HLB Co., Ltd. entered into a contract to acquire 18.4% stake in KNOTUS Co.,Ltd from Jeong In-seong and Kim Do-hyung for KRW 56.2 billion.	27/12/21
KNOTUS Co.,Ltd announced that it expects to receive KRW 94.6 billion in funding	27/12/21
KNOTUS Co.,Ltd(KOSDAQ:A278650) added to S&P Global BMI Index	20/09/21
Tranche Update on KNOTUS Co.,Ltd's Equity Buyback Plan announced on March 13, 2020.	14/06/21
Tranche Update on KNOTUS Co.,Ltd's Equity Buyback Plan announced on March 13, 2020.	14/06/21
KNOTUS Co.,Ltd's Equity Buyback Plan Extended till March 12, 2022.	12/03/21

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues HLB bioStep Co.,Ltd.

Actions

A278650

KR7278650007

Autres langues

Filtres